About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 24 record(s)
Nothing to report this month
Organization: Public Sector Pension Investment Board
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A2021-02
List of all of PSPIB’s investment securities related to "bail-in-able" bank debt from the largest 6 banks in Canada, including amounts owned, and other information at the end of FY20’s last quarter, and any Board materials pertaining to bail-in-able debt, not limited to Canada, from 2010 to March 31, 2020.Organization: Public Sector Pension Investment Board
July 2020
Req # A2020-08
List of every property owned by PSP including: name (if applicable) and address; sector of property; whether the property collects revenue from Canadian federal publicly funded programs and subsidies that would relate to the property (limited to housing programs, property tax credits, rental subsidies, renovation credits); known partners and whether partner(s) receive same or other Canadian federally publicly funded program funding/subsidies applied toward the asset(s). All email correspondence concerning the properties with all current MPs and PSP employees and Board of Directors from October 2008 to present. Whether questions around potential conflict of interests were considered for the listed assets when acquired by PSP.Organization: Public Sector Pension Investment Board
June 2020
Req # A2021-01
Copy of PSP's Series 12 Notes; list of all oil and gas extraction companies that PSP's Natural Resources and Infrastructure teams directly invested in since 1999 (all acquired and sold companies since 1999); list of all health insurance companies that the Private Equity team directly invested in, including the name of each investment partner in each transaction (all purchased and sold since 1999).Organization: Public Sector Pension Investment Board
June 2020
Nothing to report this month
Organization: Public Sector Pension Investment Board